Biosimulation Market: Which geography would provide most opportunities in the next 5 years?
The global biosimulation market is projected to reach USD 2.88 Billion by 2022 from USD 1.38 Billion in 2017, at a CAGR of 15.9%. Factors such as increase in R&D investments in the pharmaceutical and biotechnology industries, growing adoption of biosimulation software by regulatory bodies, technologically advanced QSP systems, need to curtail drug discovery and development costs, and growth in...
Isothermal Nucleic Acid Amplification Technologies (INAAT) Market worth $1.6 Billion by 2017
According to a new market research report, “Isothermal Nucleic Acid Amplification Technologies (INAAT) Market (2012-2017)”, published by MarketsandMarkets (www.marketsandmarkets.com), Isothermal nucleic acid amplification technologies emphasizing on its applications and its ability to substitute PCR as an alternative for molecular diagnosis. Focus on drivers, restraints and challenges...
Autologous Cell Therapy Market worth $2.2 Billion by 2017
he report “Autologous Cell Therapy (ACT) Market (2012 – 2017)”, published by MarketsandMarkets (www.marketsandmarkets.com), would be the first global and exclusive report on ACT market. It also gives clear information about the complete industry, approved products and potential market size; it also identifies driving and restraining factors for the global ACT market with analysis...